Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
Name (Synonyms) | Correlation | |
---|---|---|
drug3787 | Stools Wiki | 1.00 |
drug690 | CDC training Wiki | 1.00 |
drug4410 | blood tests Wiki | 1.00 |
Name (Synonyms) | Correlation | |
---|---|---|
D025241 | Spondylarthritis NIH | 0.58 |
D001172 | Arthritis, Rheumatoid NIH | 0.27 |
D001168 | Arthritis NIH | 0.23 |
Name (Synonyms) | Correlation | |
---|---|---|
HP:0001370 | Rheumatoid arthritis HPO | 0.27 |
HP:0001369 | Arthritis HPO | 0.23 |
Navigate: Correlations HPO
There is one clinical trial.
Nursing homes are ground zero for the COVID-19 pandemic.Pennsylvania (PA) nursing homes are particularly devastated with 13,485 cases of COVID-19 and more than 2,800 deaths, accounting for 65% of the state's coronavirus deaths. Nursing homes are ill-equipped for the pandemic; though facilities are required to have infection control staff, only 3% have taken a basic infection control course.Significant research has focused on infection control in the acute care setting.However,little is known about the implementation of practices and effective interventions in long-term care facilities.The investigators propose an intervention utilizing Project ECHO, an evidence-based telehealth model, to connect Penn State University experts with remote nursing home staff and administrators to proactively support evidence-based infection control guideline implementation. Our study seeks to answer the critical research question of how evidence-based infection control guidelines can be implemented effectively in nursing homes
Description: Rate of COVID-19 infection in enrolled nursing homes
Measure: Infection rate Time: 2 yearsDescription: Number of COVID-19 hospitalizations from enrolled nursing homes
Measure: Hospitalization Time: 2 yearsDescription: Number of COVID-19 deaths from enrolled nursing homes
Measure: Death Time: 2 yearsAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports